A Study of Combined Deferasirox, Vitamin D and Azacytidine in High Risk MDS
Clinical trial NCT01718366 · UNKNOWN
Trial details
- NCT number
- NCT01718366
- Sponsor
- Groupe Francophone des Myelodysplasies
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-01
- Primary completion
- 2019-02-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.